A rare case of papillary pneumocytoma of the lung is reported. The immunohistochemical positivities for EMA, cytokeratin and TTF-l strongly support the hypothesis that the neoplastic cells are originated from type 2 pneumocytes. The tumour also presented areas displaying stroma of non-specific mixoid appearance, simulating a benign tumour of the salivary gland type. We propose that these mixoid areas constitute structures of metaplastic origin.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Cytologic Findings and Ancillary Tests Results of Sclerosing Pneumocytoma: Our Institutional Experience.
Diagn Cytopathol
January 2025
Department of Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland, Ohio, USA.
Introduction: Sclerosing pneumocytoma (SP) is a rare benign tumor and a potential diagnostic pitfall. Our aim was to review the cytologic features of our surgically diagnosed SP cases including the clinical, immunohistochemical and available molecular findings.
Materials And Methods: A computerized search from 2013 to 2020 for surgical cases with corresponding cytology specimens diagnosed as SP was performed.
Navigating the diagnostic maze: the challenge of sclerosing pneumocytoma in frozen sections.
Int J Clin Exp Pathol
June 2024
Department of Pathology and Laboratory Medicine, Temple University Hospital Philadelphia, PA, USA.
Pulmonary Sclerosing Pneumocytoma (PSP) represents a rare benign tumor that exhibits a predisposition towards females. Often asymptomatic, its identification usually occurs incidentally through imaging modalities. Histologically, PSP demonstrates features consistent with pneumocytic differentiation and possesses a dual-cell population.
View Article and Find Full Text PDFPulmonary sclerosing pneumocytoma mimicking a low-grade primary malignancy: A case report.
Int J Surg Case Rep
June 2024
Department of General Thoracic Surgery, Seirei Hamamatsu General Hospital, 2-12-12, Sumiyoshi, Naka-ku, Hamamatsu-city, Shizuoka 430-8558, Japan. Electronic address:
Introduction: Pulmonary sclerosing pneumocytoma (PSP) is a rare benign tumor classified as a pulmonary adenoma. It presents as a solitary pulmonary nodule without any specific findings, often posing a diagnostic challenge. We herein present a case of a PSP with a short volume doubling time (VDT) comparable to low-grade pulmonary malignancies.
View Article and Find Full Text PDFTwo tumors with combined features of bronchiolar adenoma/ciliated muconodular papillary tumor and sclerosing pneumocytoma.
Am J Clin Pathol
December 2023
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, US.
Objectives: Bronchiolar adenoma/ciliated muconodular papillary tumor (BA/CMPT) and sclerosing pneumocytoma (SP) are both rare and morphologically unique peripheral lung tumors with indolent behavior. These tumors have not been previously described as showing overlapping morphologic features and are generally genetically distinct.
Methods: Two cases were recently encountered that show hybrid morphologic features between BA/CMPT and SP, and the morphology and immunophenotype are described in detail.
Characteristics of Metastatic and Nonmetastatic Pulmonary Sclerosing Pneumocytomas: A Clinicopathological Study of 68 Cases and 15 Reported Metastatic Cases.
Lab Invest
July 2023
Department of Pathology, Peking University Shenzhen Hospital, Shenzhen, China. Electronic address:
Article Synopsis
- The study examined 68 cases of pulmonary sclerosing pneumocytoma (PSP), revealing a low rate of metastasis (1.47%), predominantly affecting females with a mean age of 1.75 cm tumor size.
- Most tumors exhibited multiple patterns (papillary, sclerotic, solid, hemorrhagic), with consistent expression of specific markers (100% for thyroid transcription factor 1 and epithelial membrane antigen).
- No BRAF V600E mutations were found in PSP cases; however, AKT1 p.E17K mutations were identified in a case with lymph node metastasis, suggesting that while most PSP tumors are benign, some may show malignant behavior.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!